Tatiana I. Kotkina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tatiana I. Kotkina has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra M. Shchinova
Chazov National Medical Research Center of Cardiology
1 shared publication - Alexandra Potekhina
Laboratory of Myocardial Fibrosis and Heart Failure with Preserved Ejection Fraction, National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Academician Chazov St., 15a, 121552 Moscow, Russia
1 shared publication - Anastasiia Yurievna Filatova
Laboratory of Myocardial Fibrosis and Heart Failure with Preserved Ejection Fraction, National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Academician Chazov St., 15a, 121552 Moscow, Russia
1 shared publication - Anatoliy N. Samko
National Medical Research Center of Cardiology
1 shared publication - Anatoliy Nikolaevich Rogoza
E.I. Chazov National Medical Research Center Of Cardiology
1 shared publication - Anatoliy Samko
National Medical Research Center of Cardiology
1 shared publication
Latest Publications
- Open Access
- 10 January 2021
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 93 (1) , 59-65
Analysis of the causes of repeat stenosis of the coronary arteries after elective stenting in patients with stable angina pectoris
Aim. Coronary stenting is the evidence-based treatment approach of stable angina. The objective was to determine the incidence of restenosis or atherosclerosis progression which led to the need for coronary angiography according to a single center registry data. Materials and methods. The procedure and clinical data of 3732 (2897 males) consecutive stable coronary artery disease patients undergoing coronary stenting, over five years between March 2010 and September 2014, were subject of this study. Over the next 4 years, 1487 (1173 males) patients were re-evaluated due to angina reoccurrence. 699 patients demonstrated the indications for coronary angiography. Results. The restenosis of the previously stented segment was detected in 84 (12%) cases, the progression of coronary atherosclerosis in 306 (44%), the combination of restenosis and atherosclerosis progression in 63 (9%), and the absence of these complications in 245 (35%) cases. The progression of coronary atherosclerosis was the leading indication for the repeat angiography and revascularization (44 and 58%, respectively); p0.05. The basal level of hsCRP2 mg/l had a prognostic significance for the development of combined event (the restenosis and atherosclerosis progression): AUC 0.65 (0.500.75), OR 3.0 (1.17.9), p0.05. Conclusion. The progression of coronary atherosclerosis was the leading indication for the repeat angiography and repeat revascularization during 2 years after coronary stenting. The hsCRP level 2 mg/l at baseline had a prognostic significance for the development of restenosis in previously stented segment and coronary atherosclerosis progression.
- 10 January 2021
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 93 (1) , 59-65
Open AccessAnalysis of the causes of repeat stenosis of the coronary arteries after elective stenting in patients with stable angina pectoris
Aim. Coronary stenting is the evidence-based treatment approach of stable angina. The objective was to determine the incidence of restenosis or atherosclerosis progression which led to the need for coronary angiography according to a single center registry data. Materials and methods. The procedure and clinical data of 3732 (2897 males) consecutive stable coronary artery disease patients undergoing coronary stenting, over five years between March 2010 and September 2014, were subject of this study. Over the next 4 years, 1487 (1173 males) patients were re-evaluated due to angina reoccurrence. 699 patients demonstrated the indications for coronary angiography. Results. The restenosis of the previously stented segment was detected in 84 (12%) cases, the progression of coronary atherosclerosis in 306 (44%), the combination of restenosis and atherosclerosis progression in 63 (9%), and the absence of these complications in 245 (35%) cases. The progression of coronary atherosclerosis was the leading indication for the repeat angiography and revascularization (44 and 58%, respectively); p0.05. The basal level of hsCRP2 mg/l had a prognostic significance for the development of combined event (the restenosis and atherosclerosis progression): AUC 0.65 (0.500.75), OR 3.0 (1.17.9), p0.05. Conclusion. The progression of coronary atherosclerosis was the leading indication for the repeat angiography and repeat revascularization during 2 years after coronary stenting. The hsCRP level 2 mg/l at baseline had a prognostic significance for the development of restenosis in previously stented segment and coronary atherosclerosis progression.
- Open Access
- 14 June 2019
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- No. 5,p. 44-51
Nicorandil in the prevention of cardiac damage and type 4A myocardial infarction with planned percutaneous coronary intervention in patients with atherosclerosis of coronary arteries
Никорандил в предупреждении повреждения и инфаркта миокарда 4А типа при плановом чрескожном коронарном вмешательстве у больных с атеросклерозом коронарных артерий
- 14 June 2019
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- No. 5,p. 44-51
Open AccessNicorandil in the prevention of cardiac damage and type 4A myocardial infarction with planned percutaneous coronary intervention in patients with atherosclerosis of coronary arteries
Никорандил в предупреждении повреждения и инфаркта миокарда 4А типа при плановом чрескожном коронарном вмешательстве у больных с атеросклерозом коронарных артерий